| 101257-4 | Silica clotting time W excess phospholipid actual/normal of Platelet poor plasma | COAG |
| 101258-2 | MDS v3.0 - RAI v1.18.11 - Identification Information during assessment period | PANEL.SURVEY.CMS |
| 101259-0 | MDS v3.0 - RAI v1.18.11 - Hearing, Speech, and Vision during assessment period | PANEL.SURVEY.CMS |
| 10126-1 | ST wave mid displacement in lead V3 | EKG.MEAS |
| 101260-8 | MDS v3.0 - RAI v1.18.11 - Cognitive Patterns during assessment period | PANEL.SURVEY.CMS |
| 101261-6 | MDS v3.0 - RAI v1.18.11 - Mood during assessment period | PANEL.SURVEY.CMS |
| 101262-4 | MDS v3.0 - RAI v1.18.11 - Behavior during assessment period | PANEL.SURVEY.CMS |
| 101263-2 | MDS v3.0 - RAI v1.18.11 - Preferences for Customary Routine and Activities during assessment period | PANEL.SURVEY.CMS |
| 101264-0 | MDS v3.0 - RAI v1.18.11 - Functional Abilities and Goals during assessment period | PANEL.SURVEY.CMS |
| 101265-7 | MDS v3.0 - RAI v1.18.11 - Functional Abilities and Goals - Admission during assessment period | PANEL.SURVEY.CMS |
| 101266-5 | MDS v3.0 - RAI v1.18.11 - Functional Abilities and Goals - Discharge during assessment period | PANEL.SURVEY.CMS |
| 101267-3 | MDS v3.0 - RAI v1.18.11 - Functional Abilities and Goals - OBRA/Interim during assessment period | PANEL.SURVEY.CMS |
| 101268-1 | MDS v3.0 - RAI v1.18.11 - Bladder and Bowel during assessment period | PANEL.SURVEY.CMS |
| 101269-9 | MDS v3.0 - RAI v1.18.11 - Active Diagnoses during assessment period | PANEL.SURVEY.CMS |
| 10127-9 | ST wave mid displacement in lead V4 | EKG.MEAS |
| 101270-7 | MDS v3.0 - RAI v1.18.11 - Health Conditions during assessment period | PANEL.SURVEY.CMS |
| 101271-5 | MDS v3.0 - RAI v1.18.11 - Swallowing/Nutritional Status during assessment period | PANEL.SURVEY.CMS |
| 101272-3 | MDS v3.0 - RAI v1.18.11 - Oral/Dental Status during assessment period | PANEL.SURVEY.CMS |
| 101273-1 | MDS v3.0 - RAI v1.18.11 - Skin Conditions during assessment period | PANEL.SURVEY.CMS |
| 101274-9 | MDS v3.0 - RAI v1.18.11 - Medications during assessment period | PANEL.SURVEY.CMS |
| 101275-6 | MDS v3.0 - RAI v1.18.11 - Header - Special Treatments, Procedures, and Programs | PANEL.SURVEY.CMS |
| 101276-4 | MDS v3.0 - RAI v1.18.11 - Restraints and Alarms during assessment period | PANEL.SURVEY.CMS |
| 101277-2 | MDS v3.0 - RAI v1.18.11 - Header - Participation in Assessment and Goal Setting | PANEL.SURVEY.CMS |
| 101278-0 | MDS v3.0 - RAI v1.18.11 - Care Area Assessment (CAA) Summary during assessment period | PANEL.SURVEY.CMS |
| 101279-8 | MDS v3.0 - RAI v1.18.11 - Correction Request during assessment period | PANEL.SURVEY.CMS |
| 10128-7 | ST wave mid displacement in lead V5 | EKG.MEAS |
| 101280-6 | MDS v3.0 - RAI v1.18.11 - Assessment Administration during assessment period | PANEL.SURVEY.CMS |
| 101281-4 | Neurofilament light chain (immunoassay) | CHEM |
| 101282-2 | Mitragynine in Cord tissue (qualitative) | DRUG/TOX |
| 101283-0 | Speciociliatine in Cord tissue (qualitative) | DRUG/TOX |
| 101284-8 | Bordetella pertussis DNA in Nasopharynx (qualitative, naa with non-probe detection) | MICRO |
| 101285-5 | Pharyngeal pathogens DNA and RNA panel - Throat (naa with non-probe detection) | PANEL.MICRO |
| 101286-3 | Adenovirus DNA in Throat (qualitative, naa with non-probe detection) | MICRO |
| 101287-1 | Chlamydophila pneumoniae DNA in Throat (qualitative, naa with non-probe detection) | MICRO |
| 101288-9 | Human coronavirus 229E+HKU1+NL63+OC43 RNA in Throat (qualitative, naa with non-probe detection) | MICRO |
| 101289-7 | SARS-CoV-2 (COVID-19) RNA in Throat (qualitative, naa with non-probe detection) | MICRO |
| 10129-5 | ST wave mid displacement in lead V6 | EKG.MEAS |
| 101290-5 | Human metapneumovirus RNA in Throat (qualitative, naa with non-probe detection) | MICRO |
| 101291-3 | Rhinovirus+Enterovirus RNA in Throat (qualitative, naa with non-probe detection) | MICRO |
| 101292-1 | Influenza virus A RNA in Throat (qualitative, naa with non-probe detection) | MICRO |
| 101293-9 | Influenza virus A H1 2009 pandemic RNA in Throat (qualitative, naa with non-probe detection) | MICRO |
| 101294-7 | Influenza virus A H3 RNA in Throat (qualitative, naa with non-probe detection) | MICRO |
| 101295-4 | Influenza virus B RNA in Throat (qualitative, naa with non-probe detection) | MICRO |
| 101296-2 | Mycoplasma pneumoniae DNA in Throat (qualitative, naa with non-probe detection) | MICRO |
| 101297-0 | Parainfluenza virus 1+2+3+4 RNA in Throat (qualitative, naa with non-probe detection) | MICRO |
| 101298-8 | Respiratory syncytial virus RNA in Throat (qualitative, naa with non-probe detection) | MICRO |
| 101299-6 | Streptococcus dysgalactiae subspecies equisimilis DNA in Throat (qualitative, naa with non-probe detection) | MICRO |
| 1013-2 | E sup(w) Ag on Red Blood Cells from Blood product unit (qualitative) | BLDBK |
| 10130-3 | T' wave amplitude in lead AVF | EKG.MEAS |
| 101300-2 | Streptococcus pyogenes DNA in Throat (qualitative, naa with non-probe detection) | MICRO |